US FDA decisions: a new milestone for IQOS
IQOS
Please enter your date of birth to confirm you are an adult user of nicotine or tobacco products.
Month
Month*
January
February
March
April
May
June
July
August
September
October
November
December
Year
Year*
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
1979
1978
1977
1976
1975
1974
1973
1972
1971
1970
1969
1968
1967
1966
1965
1964
1963
1962
1961
1960
1959
1958
1957
1956
1955
1954
1953
1952
1951
1950
1949
1948
1947
1946
1945
1944
1943
1942
1941
1940

We Care

This website contains information about our smoke-free products and we need your age to make sure that you are an adult in Lebanon who would otherwise continue to smoke or use nicotine products. Our nicotine and tobacco products are not an alternative to quitting and are not designed as cessation aids. They are not risk free. They contain nicotine, which is addictive. Only for use by adults. Please visit the Important Information page of this website for further risk information.
BACK
lucid-teal

US FDA decisions: a new milestone for IQOS

On July 7, 2020, the US Food and Drug Administration (FDA), a government agency responsible for protecting public health, made a historic decision concerning IQOS. It authorized IQOS and three HeatSticks variants, to be marketed in the US as a modified risk tobacco product (MRTP), with a reduced exposure claim.

IQOS is the first and only tobacco heating system that has completed the US FDA Modified Risk Tobacco Product application process, concluding that switching completely to IQOS reduces your body’s exposure to harmful or potentially harmful chemicals*.

The FDA’s decisions came after several years of reviews of the scientific evidence available on IQOS.

After having reviewed the totality of scientific evidence available for IQOS, the US FDA concluded that:
  • IQOS heats tobacco but does not burn it.
  • The absence of combustion significantly reduces the production of harmful or potentially harmful chemicals.
  • Scientific evidence have shown that switching completely from conventional cigarettes to IQOS significantly reduces your body’s exposure to harmful or potentially harmful chemicals**.


The FDA’s decisions show that IQOS is a fundamentally different product compared to cigarettes. IQOS is a better choice for adults who would otherwise continue smoking. Unlike cigarettes, which burn tobacco, IQOS heats it instead. This significantly reduces the production of harmful or potentially harmful chemicals compared to cigarette smoke.

For the past 10 years, we built a team of more than 400 scientists and R&D experts and have significantly invested towards one goal: creating an alternative to cigarettes for those adult smokers who want a better choice than continued smoking.
So we are proud to celebrate this milestone on our journey, together we aim to prove ourselves step by step and continue delivering on our promises.

Important information: IQOS is not risk-free. It delivers nicotine, which is addictive.

* Source: PMI 3-month reduced exposure studies conducted in Japan and the US in near real world conditions. These studies measured exposure to 15 harmful chemicals, and compared to the levels observed in smokers who switched to IQOS with levels measured in smokers who continued to smoke cigarettes.
**Source:  FDA’s marketing order for the IQOS system dated July 7, 2020.

This Product damages your health and is addictive.

هذا المنتج يضر بالصحة ويسبب الإدمان